Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro-and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in E. coli a fusion protein consisting of large extracellular loop of CD81 receptor and streptavidin as spacing part. The obtained protein has been immobilized on the surface of PLA-based micro-and nanoparticles. The developed trapping systems were characterized in terms of their physico-chemical properties. In order to illustrate the ability of developed micro-and nanotraps to bind HCV, E2 core protein of HCV was synthesized as a fusion protein with GFP. Interaction of E2 protein and hepatitis C virus-mimicking particles with the developed trapping systems were testified by several methods.

Original languageEnglish
Article number672
Number of pages18
JournalPharmaceutics
Volume13
Issue number5
DOIs
StatePublished - 7 May 2021

    Scopus subject areas

  • Pharmaceutical Science

    Research areas

  • Interaction of LEL CD81 with E2 protein, Poly(lactic acid)-based micro-and nanoparticles, Recombinant CD81-streptavidin fusion protein, Trapping system for HCV, Virus-mimicking particles, recombinant CD81-streptavidin fusion protein, SIZE, NANOTRAP, ENVELOPE PROTEINS, IDENTIFICATION, E2, virus-mimicking particles, NANOPARTICLES, trapping system for HCV, poly(lactic acid)-based micro- and nanoparticles, PURIFICATION, interaction of LEL CD81 with E2 protein, ALBUMIN, MICRO, EXPRESSION

ID: 83919888